Transactions Are Undermined by What Is Assumed, Not What Is Visible
Regulatory ratings often lag behind real performance. Commercial assumptions may not reflect what the operation can actually sustain. Workforce models that look stable on paper can carry significant cost and continuity risk. High-harm exposure may exist at a level that creates reputational, legal or coroner-level consequence. And the gap between documented position and operational reality only becomes visible when someone looks properly.
These are the gaps that create post-acquisition surprises - regulatory action, enforcement, commissioner withdrawal, staffing crises and reputational damage.
Regulatory ratings often lag behind real performance
Commercial and occupancy assumptions may not reflect sustainable reality
Workforce models can carry hidden cost and continuity risk
High-harm exposure may create consequences beyond compliance
Documented position frequently diverges from operational reality
Acquisition Due Diligence
Operational due diligence across the full transaction. For providers preparing to sell, and investors and acquirers who need to know what they're actually buying.
Standard due diligence tells you what has happened. It does not reliably tell you what will happen next. EMLR's Acquisition Due Diligence goes beyond documentation and historic performance to give providers the operational clarity they need before going to market, support a clean and credible process, and give investors confidence in what they are committing to post-close.
How It Works
Core Quality and Governance Review
A structured assessment of service-level performance and risk, including review of regulatory history, inspections and commissioner intelligence; analysis of incidents, safeguarding, complaints and whistleblowing; training compliance, supervision and workforce oversight; observation of care delivery and staff engagement; and sampling of care plans, risk assessments and documentation. This establishes the baseline level of control and identifies barriers to improvement.
Harm and High-Risk Exposure
Focused assessment of the areas most likely to drive serious incidents, regulatory escalation or reputational damage, including medicines governance and administration reliability, restrictive practice and legal positioning, escalation pathways and incident response, learning following near-miss events, and high-acuity and complex care risk. This tests whether the service is resilient under pressure and identifies barriers to safe, sustainable delivery.
Operational and Commercial Risk
An assessment of sustainability and deal exposure, including occupancy stability and admissions pipeline, commissioner and funding dependency, workforce model and cost sensitivity, leadership capacity and platform maturity, and alignment between the business model and operational reality. This identifies risks that may impact valuation or post-close performance, including barriers to occupancy growth and commercial stability.
Our Methodology
EMLR uses a structured, operator-led approach that combines intelligence-led pre-assessment with on-site observation and real-time testing of practice. This includes direct engagement with staff to assess confidence, understanding and escalation behaviour, alongside triangulation of evidence across records, incidents and observed care.
The approach is designed to identify any disconnect between reported performance and operational reality, ensuring a clear view of how the service functions under normal and pressured conditions. Findings are grounded in how services operate in practice, not how they are presented.
